CoChat

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

Ishihara, Lianna, Gibson, Rachel A., Warren, Liling, Amouri, Rim, Lyons, Kelly, Wielinski, Catherine, Hunter, Christine, Swartz, Jina E., Elango, Ramu, Akkari, P. Anthony, Leppert, David, Surh, Linda, Reeves, Kevin H., Thomas, Siwan, Ragone, Leigh, Hattori, Nobutaka, Pahwa, Rajesh, Jankovic, Joseph, Nance, Martha, Freeman, Alan, Gouider‐Khouja, Neziha, Kefi, Mounir, Zouari, Mourad, Ben Sassi, Samia, Ben Yahmed, Samia, El Euch‐Fayeche, Ghada, Middleton, Lefkos, Burn, David J., Watts, Ray L., Hentati, Faycal · 2007 · Movement Disorders
Cited by 93

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Mutations in the leucine‐rich repeat kinase‐2 gene (LRRK2) are responsible for some forms of familial as well as sporadic Parkinson's disease (PD). The purpose of this study was to examine the frequency of a single pathogenic mutation (6055G>A) in the kinase domain of this gene in United States and Tunisian familial PD and to compare clinical characteristics between patients with and without the mutation. Standardized case report forms were used for clinical and demographic data collection. We investigated the frequency of the most common substitution of LRRK2 (G2019S, 6055G>A) and its impact on epidemiological and phenotypic features. The frequency of mutations in Tunisian families was 42% (38/91) and in U.S. families 2.6% (1/39), with the unique opportunity to compare homozygous (n = 23) and heterozygous (n = 109) Tunisian carriers of G2019S substitutions. Individuals with G2019S substitutions had an older age at onset but few other differences compared with families negative for the substitution. Patients with LRRK2 mutations had typical clinical features of PD. Comparisons between individuals with heterozygous and homozygous LRRK2 mutations suggested that gene dosage was not correlated with phenotypic differences; however, the estimated penetrance was greater in homozygotes across all age groups. © 2006 Movement Disorder Society

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/mds.21180

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

Metadata

Authors
Ishihara, L., Gibson, R. A., Warren, L., Amouri, R., Lyons, K., Wielinski, C., Hunter, C., Swartz, J. E., Elango, R., Akkari, P. A., Leppert, D., Surh, L., Reeves, K. H., Thomas, S., Ragone, L., Hattori, N., Pahwa, R., Jankovic, J., Nance, M., Freeman, A., Gouider‐Khouja, N., Kefi, M., Zouari, M., Ben Sassi, S., Ben Yahmed, S., El Euch‐Fayeche, G., Middleton, L., Burn, D. J., Watts, R. L., & Hentati, F.
Venue
Movement Disorders
Publisher
Wiley
Published
2007-01
Volume
22
Issue
1
Pages
55-61
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2003198613
Cited by
93
References
3
FWCI
5.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.